Are anxiety and depression social problems or chemical disorders?
As antidepressants will soon be a $16B industry, the chemical imbalance theory suits business interests better than health interests.
Using AI, MIT researchers identify a new class of antibiotic candidates
Using a type of artificial intelligence, MIT researchers have discovered a class of compounds that can kill drug-resistant bacteria.
Psychoactive drug ibogaine helps veterans with TBI
A small study found that one dose of ibogaine could reduce the symptoms of a traumatic brain injury (TBI) for military vets.
How a mutation in microglia elevates Alzheimer’s risk
A study finds that microglia with mutant TREM2 protein reduce brain circuit connections, promote inflammation, and contribute to Alzheimer’s.
Superbug-killing antibiotic is now in human trials
A promising new antibiotic that kills a superbug resistant to nearly all available drugs is now being tested in people.
Nutrition professor answers: Does chicken soup really help when you’re sick?
Is chicken soup just a comforting placebo, providing psychological benefit while we’re sick, without an actual therapeutic effect?
Moderna’s mRNA cancer vaccine works even better than thought
Adding Moderna’s mRNA cancer vaccine to a standard melanoma treatment dramatically reduces the risk of death or recurrence.
The 5 most exciting clinical trial results of 2023
In 2023, several potentially game-changing meds, including ones to treat pain and high cholesterol, showed huge promise in human trials.
Chemobrain is real. Here’s what to expect after cancer treatment.
Chemobrain, or chemofog, can significantly affect cancer survivors' quality of life with its social, psychological, and economic impacts.